Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33877899)
Watch
English
Assessment of HER2 status in breast cancer: why, when and how?
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Assessment of HER2 status in breast cancer: why, when and how?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
author
Ian Ellis
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
author name string
M Dowsett
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
T Cooke
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
W J Gullick
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
B Gusterson
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
E Mallon
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
R Walker
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
publication date
1 January 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
volume
36
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
page(s)
170-176
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
cites work
Specificity within the EGF family/ErbB receptor family signaling network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Receptor protein-tyrosine kinases and their signal transduction pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The biology of erbB-2/neu/HER-2 and its role in cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ELISA for quantitation of the extracellular domain of p185HER2 in biological fluids
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative radioimmunohistochemical measurements of p185(erbB-2) in frozen tissue sections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of c-erbB(2) and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of cerbB2 expression using a panel of 6 commercially available antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Optimization of immunohistochemical detection of ERBB2 in human breast cancer: impact of fixation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The HercepTest assay: another perspective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased HER2 with U.S. Food and Drug Administration-approved antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of the c-erbB-2 protein in human breast tumor cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900264-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(99)00264-6
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
PubMed ID
10741274
1 reference
stated in
Europe PubMed Central
PubMed ID
10741274
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10741274%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit